From: A systematic review of economic evaluations of cervical cancer screening methods
Dominant screening strategy | ||||
---|---|---|---|---|
Study | HPV based | Cytology based | VIA based | Other |
De Kok et al. 2012 [47] | X | Â | Â | Â |
Campos et al. 2014 [34] | X | Â | Â | Â |
Pista et al. 2019 [48] | X | Â | Â | Â |
Skroumpelos et al. 2019 [49] | Â | Â | Â | X |
Termrungruanglert et al. 2019 [50] | X | Â | Â | Â |
Vassilakos et al. 2019 [51] | X | Â | Â | Â |
Campos et al. 2018 [21] | X | Â | Â | Â |
Mezei et al. 2018 [52] | X | Â | Â | Â |
Lew et al. 2018 [53] | X | Â | Â | Â |
Barre et al. 2017 [54] | X | Â | Â | Â |
Campos et al. 2017 [55] | X | Â | Â | Â |
Jin et al. 2016 [56] | X | Â | Â | Â |
Burger et al. 2012 [57] | Â | X | Â | Â |
Flores et al. 2010 [58] | Â | X | Â | Â |
Sroczynski et al. 2011 [45] | X | Â | Â | Â |
Kim et al. 2005 [39] | X | Â | Â | Â |
Sherlaw-Johnson et al. 2004 [59] | X | Â | Â | Â |
Chow et al. 2010 [60] | X | Â | Â | Â |
Campos et al. 2012 [46] | X | Â | Â | Â |
Beal et al. 2014 [61] | X | Â | Â | Â |
Tantinamit et al. 2019 [62] | Â | Â | Â | X |
Vale et al. 2021 [63] | X | Â | Â | Â |
Berkhof et al. 2010 [64] | X | Â | Â | Â |
Vanni et al. 2011 [65] | X | Â | Â | Â |
Lew et al. 2016 [37] | X | Â | Â | Â |
Felix et al. 2016 [66] | Â | X | Â | Â |